×

Alzheimer’s disease: analysis of a mathematical model incorporating the role of prions. (English) Zbl 1307.35305

Authors’ abstract: We introduce a mathematical model of the in vivo progression of Alzheimer’s disease with focus on the role of prions in memory impairment. Our model consists of differential equations that describe the dynamic formation of \(\beta \)-amyloid plaques based on the concentrations of A\(\beta\) oligomers, PrP\(^C\) proteins, and the A\(\beta\)-\(\times\)-PrP\(^C\) complex, which are hypothesized to be responsible for synaptic toxicity. We prove the well-posedness of the model and provided stability results for its unique equilibrium, when the polymerization rate of \(\beta \)-amyloid is constant and also when it is described by a power law.

MSC:

35Q92 PDEs in connection with biology, chemistry and other natural sciences
92C50 Medical applications (general)
35B35 Stability in context of PDEs
35F61 Initial-boundary value problems for systems of nonlinear first-order PDEs
92B05 General biology and biomathematics
34L30 Nonlinear ordinary differential operators

References:

[1] Achdou Y, Franchi B, Marcello N, Tesi M (2012) A qualitative model for aggregation and diffusion of \[\beta\] β-amyloid in alzheimers disease. J Math Biol 1-24
[2] Allen LJS (2007) An introduction to mathematical biology. Pearson/Prentice Hall, Upper Saddle River
[3] Calvez V, Lenuzza N, Oelz D, Deslys JP, Laurent P, Mouthon F, Perthame B (2009) Size distribution dependence of prion aggregates infectivity. Math Biosci 217(1):88-99 · Zbl 1161.92033 · doi:10.1016/j.mbs.2008.10.007
[4] Calvez V, Lenuzza N, Doumic M, Deslys JP, Mouthon F, Perthame B (2010) Prion dynamics with size dependency-strain phenomena. J Biol Dyn 4(1):28-42 · Zbl 1315.92039 · doi:10.1080/17513750902935208
[5] Chen S, Yadav SP, Surewicz WK (2010) Interaction between human prion protein and amyloid-\[ \beta\] β (a \[\beta\] β) oligomers role of N-terminal residues. J Biol Chem 285(34):26,377-26,383 · doi:10.1074/jbc.M110.145516
[6] Chung E, Ji Y, Sun Y, Kascsak R, Kascsak R, Mehta P, Strittmatter S, Wisniewski T (2010) Anti-prpc monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer’s disease model mouse. BMC Neurosci 11(1):130 · doi:10.1186/1471-2202-11-130
[7] Cissé M, Mucke L (2009) Alzheimer’s disease: a prion protein connection. Nature 457(7233):1090-1091 · doi:10.1038/4571090a
[8] Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P et al (2011) Reversing ephb2 depletion rescues cognitive functions in alzheimer model. Nature 469(7328):47-52 · doi:10.1038/nature09635
[9] Collet JF, Goudon T (2000) On solutions of the lifshitz-slyozov model. Nonlinearity 13(4):1239 · Zbl 0957.35127 · doi:10.1088/0951-7715/13/4/314
[10] Craft DL, Wein LM, Selkoe DJ (2002) A mathematical model of the impact of novel treatments on the a \[\beta\] β burden in the alzheimers brain, csf and plasma. Bull Math Biol 64(5):1011-1031 · Zbl 1334.92068 · doi:10.1006/bulm.2002.0304
[11] Craft, DL; Wein, LM; Selkoe, DJ; Brandeau, ML (ed.); Sainfort, F. (ed.); Pierskalla, WP (ed.), The impact of novel treatments on a \[\beta\] β burden in alzheimers disease: insights from a mathematical model, No. 70, 839-865 (2005), USA · doi:10.1007/1-4020-8066-2_32
[12] Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of alzheimer disease. Acta Neuropathol 118(1):5-36 · doi:10.1007/s00401-009-0532-1
[13] Fawzi NL, Okabe Y, Yap EH, Head-Gordon T (2007) Determining the critical nucleus and mechanism of fibril elongation of the alzheimers a \[\beta_{1-40}\] β1-40 peptide. J Mol Biol 365(2):535-550 · doi:10.1016/j.jmb.2006.10.011
[14] Freir DB, Nicoll AJ, Klyubin I, Panico S, Risse E, Asante EA, Farrow MA, Sessions RB, Saibil HR, Clarke AR, Rowan MJ, Walsh DM, Collinge J (2011) Interaction between prion protein and toxic amyloid \[\beta\] β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2:336 · doi:10.1038/ncomms1341
[15] Gabriel P (2011) The shape of the polymerization rate in the prion equation. Math Comput Model 53(7):1451-1456 · Zbl 1219.35326 · doi:10.1016/j.mcm.2010.03.032
[16] Gallion SL (2012) Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein. PLoS One 7(11):e49,375 · doi:10.1371/journal.pone.0049375
[17] Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, Strittmatter SM (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30(18): 6367-6374 · Zbl 1109.92021
[18] Greer ML, Pujo-Menjouet L, Webb GF (2006) A mathematical analysis of the dynamics of prion proliferation. J Theor Biol 242(3):598-606 · Zbl 1447.92089 · doi:10.1016/j.jtbi.2006.04.010
[19] Greer ML, Van den Driessche P, Wang L, Webb GF (2007) Effects of general incidence and polymer joining on nucleated polymerization in a model of prion proliferation. SIAM J Appl Math 68(1):154-170 · Zbl 1131.92030 · doi:10.1137/06066076X
[20] Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353-356 · doi:10.1126/science.1072994
[21] Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of a \[\beta\] β42 immunisation in alzheimer’s disease: follow-up of a randomised, placebo-controlled phase i trial. The Lancet 372(9):216-223. doi:10.1016/S0140-6736(08)61075-2. http://www.sciencedirect.com/science/article/pii/S0140673608610752
[22] Khalil HK (1996) Nonlinear systems. Prentice Hall, Upper Saddle River · Zbl 0892.93002
[23] LaSalle JP (1976) The stability of dynamical systems. In: CBMS-NSF regional conference series in applied mathematics SIAM · Zbl 0364.93002
[24] Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\[ \beta\] β oligomers. Nature 457(7233):1128-1132 · doi:10.1038/nature07761
[25] Laurençot P, Walker C (2007) Well-posedness for a model of prion proliferation dynamics. J Evol Equ 7(2):241-264 · Zbl 1121.35024 · doi:10.1007/s00028-006-0279-2
[26] Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93(3):1125-1129 · doi:10.1073/pnas.93.3.1125
[27] Lomakin A, Teplow DB, Kirschner DA, B BG, (1997) Kinetic theory of fibrillogenesis of amyloid \[\beta\] β-protein. Proc Natl Acad Sci USA 94(15):7942-7947 · Zbl 1219.35326
[28] Nath S, Agholme L, Kurudenkandy FR, Granseth B, Marcusson J, Hallbeck M (2012) Spreading of neurodegenerative pathology via neuron-to-neuron transmission of \[\beta\] β-amyloid. J Neurosci 32(26):8767-8777 · doi:10.1523/JNEUROSCI.0615-12.2012
[29] Nygaard HB, Strittmatter SM (2009) Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch Neurol 66(11):1325 · doi:10.1001/archneurol.2009.223
[30] Portet S, Arino J (2009) An in vivo intermediate filament assembly model. Math Biosci Eng 6(1):117-134 · Zbl 1159.92014 · doi:10.3934/mbe.2009.6.117
[31] Prigent S, Ballesta A, Charles F, Lenuzza N, Gabriel P, Tine LM, Rezaei H, Doumic M (2012) An efficient kinetic model for assemblies of amyloid fibrils and its application to polyglutamine aggregation. PLoS One 7(11):e43,273 · doi:10.1371/journal.pone.0043273
[32] Prüss J, Pujo-Menjouet L, Webb G, Zacher R (2006) Analysis of a model for the dynamics of prions. Discret Contin Dyn Syst Ser B 6(1):225-235 · Zbl 1088.92043
[33] Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Gerd M, Winklhofer KF, Tatzelt J (2011) The cellular prion protein mediates neurotoxic signalling of \[\beta\] β-sheet-rich conformers independent of prion replication. EMBO J 30(10):2057-2070 · doi:10.1038/emboj.2011.86
[34] Rubenstein R, Merz PA, Kascsak RJ, Scalici CL, Papini MC, Carp RI, Kimberlin RH (1991) Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. J Infect Dis 164(1):29-35 · doi:10.1093/infdis/164.1.29
[35] Selkoe DJ (2008) Soluble oligomers of the amyloid \[\beta\] β-protein impair synaptic plasticity and behavior. Behav Brain Res 192(1):106-113 · doi:10.1016/j.bbr.2008.02.016
[36] Serpell LC (2000) Alzheimers amyloid fibrils: structure and assembly. Biochim Biophys Acta Mol Basis Dis 1502(1):16-30 · doi:10.1016/S0925-4439(00)00029-6
[37] Simonett G, Walker C (2006) On the solvability of a mathematical model for prion proliferation. J Math Anal Appl 324(1):580-603 · Zbl 1109.92021 · doi:10.1016/j.jmaa.2005.12.036
[38] Urbanc B, Cruz L, Buldyrev S, Havlin S, Irizarry M, Stanley H, Hyman B (1999) Dynamics of plaque formation in Alzheimer’s disease. Biophys J 76(3):1330-1334 · doi:10.1016/S0006-3495(99)77295-4
[39] Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MV, Checler F (2008) Regulation of \[\beta\] β app and prpc cleavage by \[\alpha\] α-secretase: mechanistic and therapeutic perspectives. Curr Alzheimer Res 5(2):202-211 · doi:10.2174/156720508783954749
[40] Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid \[\beta\] β-protein fibrillogenesis detection of a protofibrillar intermediate. J Biol Chem 272(35):22,364-22,372 · doi:10.1074/jbc.272.35.22364
[41] Wimo A, Prince M (2010) World Alzheimer report 2010: the global economic impact of dementia. Technical report, Alzheimer’s Disease International
[42] Zou WQ, Zhou X, Yuan J, Xiao X (2011) Insoluble cellular prion protein and its association with prion and Alzheimer diseases. Prion 5(3):172-178 · doi:10.4161/pri.5.3.16894
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.